PUNCTURABLE MEMBRANE FOR SAFETY SYRINGE
A safety syringe may define a variable fluid chamber and detached needle assembly. The variable fluid chamber may be hermetically sealed off from the environment or ambient air until the needle assembly is attached to a syringe body of the safety syringe. A proximal end of the variable fluid chamber is sealed off from the environment via a seal between a piston and syringe body. The distal end of the variable fluid chamber may be sealed off from the environment via a barrier covering the distal end of the syringe body. The barrier may be punctured to allow fluid to through tberethrough at or about the same time when the needle assembly is attached to the distal end portion of the syringe body.
This applications claims the benefits of U.S. Provisional Patent Application Ser. No. 60/857,088, the entire contents of which are incorporated herein by reference.
The entire contents of U.S. application Ser. No. 11/511,668, filed Aug. 29, 2006 is expressly incorporated herein by reference. Additionally, the entire contents of U.S. Pat. No. 6,413,236, filed Jun. 20, 2000 to Van Dyke is expressly incorporated herein by reference. Also, the entire contents of U.S. application Ser. No. 11/409,617, filed Apr. 24, 2006 is expressly incorporated herein by reference.
STATEMENT RE: FEDERALLY SPONSORED RESEARCH/DEVELOPMENTNot Applicable
BACKGROUNDThe present invention relates to a safety syringe wherein a variable fluid chamber is hermetically sealed off from contaminated ambient air until a needle assembly is attached to a syringe body such that fluidic medication may be withdrawn from a medication vial and injected into a patient in a sterile manner.
Accordingly, there is a need in the art for a device and a method for injecting fluidic medication into the patient in a sterile manner.
BRIEF SUMMARYThe safety syringe discussed herein addresses the needs discussed above, discussed below and those that are known in the art.
The safety syringe provides a sterile environment in which the fluidic medication may be withdrawn from a medication container and subsequently injected into the patient. More particularly, the safety syringe may have a barrier disposed at a distal end portion of a syringe body of the syringe. The barrier provides an impermeable air barrier between the environment (contaminated ambient air)and the variable fluid chamber. The barrier may be punctured at or about the same time when a needle assembly is attached to the syringe body. When the barrier is punctured, the needle assembly then acts as a cover such that contaminated ambient air does not enter into the variable fluid chamber after the barrier is punctured by the needle assembly. As such, at no time during the process of removing the syringe from its packaging, attaching the needle assembly to the syringe body, withdrawing fluidic medication from a medication container and injecting the patient with the fluidic medication was the variable fluid chamber exposed or allowed to have ambient air flow therein. Hence, the fluidic medication injected into the patient is performed in a sterile manner.
These and other features and advantages of the various embodiments disclosed herein will be better understood with respect to the following description and drawings, in which like numbers refer to like parts throughout, and in which:
Referring now to the drawings,
The safety syringe 10 is directed to a device and a method for maintaining sterility of fluidic medication during the entire process of withdrawing fluid medication from a medication container and injecting the fluidic medication to the patient. The safety syringe 10 accomplishes this by providing a barrier 22 between the environment which contains contaminated ambient air and a sterile variable fluid chamber 26.
In particular, the safety syringe 10 may be provided to a medical professional. The needle assembly 18 may initially be detached from the syringe body 14. Moreover, the plunger assembly 12 may be initially positioned in a retracted position when provided to the medical professional. As used herein, a retracted position of the plunger assembly is where a piston 28 of the plunger assembly 12 is closer to a proximal end of the syringe body 14 compared to a distal end portion 30 of the syringe body 14. When the safety syringe 10 is assembled by the manufacturer, the safety syringe 10 is also sterilized to kill or eliminate harmful or potentially harmful viruses, bacteria and other unwanted contaminants that may be on or in the safety syringe 10. More particularly, during the sterilization process, the inner surface of the variable fluid chamber 26 is sterilized. In particular, the inner surface of the variable fluid chamber 26 may be defined by a distal end 32 of the piston 28, an inner surface 34 of the syringe body 14 and a proximal surface 36 of the barrier 22.
In use, to administer a fluidic medication to a patient, the needle assembly 18 is attached to the distal end portion 30 of the syringe body 14. At or about the same time, the barrier 22 is punctured to allow fluidic medication to be drawn into the variable fluid chamber 26 and subsequently ejected out of the variable fluid chamber 26 and injected into the patient via the needle 20.
One of the many important aspects of the safety syringe 10 is that the inner surface of the variable fluid chamber 26 does not come into contact with the contaminated ambient air 24 during the process of attaching the needle assembly 18 to the syringe body 14. Before the needle assembly 18 is attached to the syringe body 14, the barrier 22 prevents contaminated ambient air 24 from entering into the variable fluid chamber 26. The barrier 22 is punctured to allow fluid and/or air to enter into or escape out of the variable fluid chamber 26 at or about the same time that the needle assembly 18 is attached to the syringe body 14. At such time, the needle assembly 18 then behaves as a cover after the barrier 22 is punctured such that ambient air does not enter into the variable fluid chamber 26 and possibly contaminate the variable fluid chamber 26 due to airborne viruses, bacteria or unwanted contaminants in the ambient air 24.
After the needle assembly 18 is attached to the syringe body 14, the fluidic medication may be withdrawn from a medication vial and be administered to the patient. In particular, the needle 20 of the syringe 10 may be inserted into a medication container or vial. At this time, the plunger assembly may be traversed toward the forward position. The forward position is defined where the piston 28 is closer to the distal end portion 30 of the syringe body 14 compared to a proximal end of the syringe body 14. As the plunger assembly 12 is traversed toward the forward position, sterilized air contained in the variable fluid chamber 26 is transferred into the medication container. Such transfer of sterilized air 38 increases the pressure within the medication container to assist in withdrawal of the fluidic medication therefrom. The medication container and safety syringe 10 may now be inverted such that the medication container is positioned over the safety syringe 10. A distal tip 40 of the needle 20 may be positioned within the fluidic medication contained in the medication container. Now the plunger assembly 12 may be traversed back toward the retracted position. Such retraction of the plunger assembly 12 traverses the fluidic medication contained in the medication container into the variable fluid chamber 26 of the safety syringe 10, As you will note, the fluidic medication in the variable fluid chamber 26 was not exposed to ambient air 24. The medical professional may remove the needle 20 from the medication container and remove any sterilized air 38 from within the variable fluid chamber by inverting the safety syringe 10, tapping on syringe body 14 to urge the sterilized air 38 toward the needle 20, and then slightly traversing the plunger assembly 12 toward the forward position to eject the sterilized air 38 and a negligible amount of the fluidic medication out of the variable fluid chamber 26 and the needle assembly 18. At this time, the medical professional may inject the patient with the fluidic medication contained in the variable fluid chamber 26.
In an aspect of the safety syringe 10, the needle assembly 18 may be attachable to the to the syringe body 14 in a plurality of different methods known in the art, discussed herein and those that are developed in the future. By way of example and not limitation, as shown in
In an aspect of the safety syringe 10, various types of barriers 22 arc contemplated. By way of example and not limitation, as shown in
In another aspect of the safety syringe 10, as shown in
In an aspect of the safety syringe 10, the puncturing of the barrier 22 may be controlled. In particular, as shown in
Although the score lines 56 as shown in
In an aspect of the barrier 22, the barrier 22 may be fabricated from an air impermeable material. By way of example and not limitation, the impermeable material may be plastic, paper, rubber, cloth, etc. The barrier 22 may be perforated but still be characterized as impermeable so long as a free flow of ambient air is not allowed to pass through the barrier 22 into the variable fluid chamber 26.
In another aspect of the safety syringe 10, as shown in
In an aspect of the safety syringe 10, the syringe 10 may be a sterilized vacuum assisted retractable safety syringe as discussed in U.S. application Ser. No. 11/511,668 ('668 application), filed Aug. 29, 2006, the entire content of which is incorporated herein by reference. The '688 application discusses how fluidic medication is injected into the patient in a sterile manner if the needle assembly is attached to the syringe body. In this regard, the discussion of the '668 application may he employed in the safety syringe 10 with detached needle assembly discussed herein after the detached needle assembly 18 is attached to the syringe body 14. Additionally, the safety syringe 10 may be a vacuum assisted retractable safety syringe as discussed in U.S. Pat. No. 6,413, 236, filed Jun. 20, 2000 to Van Dyke, the entire content of which is incorporated herein by reference.
The safety syringe 10 may have a variable vacuum compartment 62 (see
Although the variable vacuum compartment 62 and the variable fluid chamber 26 are separate compartments, during the process of injecting the patient with fluidic medication via the safety syringe 10, the variable fluid chamber 26 and the variable vacuum compartment 62 share a common surface, namely, the inner surface 34 of the syringe body. For example, the plunger assembly 12 is traversed between two positions, namely, the retracted position and the forward position. When the plunger assembly 12 is in the retracted position, the variable fluid chamber 26 typically has a larger volume compared to the variable vacuum compartment 62. When the plunger assembly 12 is traversed toward the forward position, the volume of the variable vacuum compartment 62 increases and the volume of the variable fluid chamber 26 decreases because the distal end 28 slides downward against the inner surface 34 of the syringe body 14. Accordingly, a portion of the inner surface 34 of the syringe body which used to define the variable fluid chamber 26 now at least partially defines the variable vacuum compartment 62.
If ambient air 24 were to enter into the variable vacuum compartment 62 via the proximal end of the syringe body 14, then contaminants contained in the ambient air 24 may be lodged onto the inner surface 34 of the syringe body. As the plunger assembly 12 is traversed between the retracted position and the forward position, the lodged contaminants on the inner surface 34 of the syringe body may eventually enter into the variable fluid chamber and thereby contaminate any fluidic medication drawn into the variable fluid chamber 26.
A benefit of the vacuum assisted retractable safety syringe is that the variable vacuum compartment 62 remains in a sterile state throughout the entire process of injecting the patient with fluidic medication because ambient air is not allowed into the variable vacuum compartment 62 via the proximal end of the syringe body 14.
Combining the vacuum assisted retractable safety syringe 10 with the barrier 22 provides a complete sterile environment in which the fluidic medication may be withdrawn into the variable fluid chamber 26 and subsequently injected into the patient without concern that the fluidic medication may become contaminated by exposure to the ambient air 24 or to contaminants that may have entered into the variable fluid chamber 26 via the proximal end of the syringe body 14.
In an aspect of the syringe 10, the detached needle assembly 18 may be attachable to the syringe body 14, as discussed in U.S. application Ser. No. 11/409,617, filed Apr. 24, 2006, the entire contents of which are expressly incorporated herein by reference. Additionally, the needle 20 of the needle assembly 18 may be retractable into the syringe body 14 as shown in U.S. application Ser. No. 11/409,617. Moreover, the barrier 22 may be attached to the distal end portion 30 of the syringe body 14 shown in
The above description is given by way of example, and not limitation. Given the above disclosure, one skilled in the art could devise variations that are within the scope and spirit of the invention disclosed herein. Further, the various features of the embodiments disclosed herein can be used alone, or in varying combinations with each other and are not intended to be limited to the specific combination described herein. Thus, the scope of the claims is not to be limited by the illustrated embodiments.
Claims
1-12. (canceled)
13. A syringe for injecting a patient with fluidic medication in a sterile manner, the syringe comprising:
- a plunger assembly having a piston and a shaft;
- a syringe body having a proximal portion and a distal portion, the piston and shaft disposed within the syringe body with the shaft extending out of the proximal portion of the body, the piston being traversable between a refracted position and a forward position within the syringe body, the piston and syringe body defining a variable fluid chamber disposed on a distal side of the piston with sterile gas disposed therein;
- a barrier disposed at the distal portion of the syringe body, the barrier configured to prevent air transfer between an environment and the variable fluid chamber and configured to maintain sterility of the variable fluid chamber; and
- a needle disposed at the distal portion of the syringe body,
- wherein the barrier is breakable to allow fluidic medication to flow into or out of the variable fluid chamber through the needle.
14. The syringe of claim 13, which includes a needle assembly including the needle, and wherein the needle assembly is detachable to the distal portion of the syringe body.
15. The syringe of claim 14, wherein a syringe end of the needle assembly is configured to puncture the barrier to allow the fluidic medication to flow into or out of the variable fluid chamber through the needle.
16. The syringe of claim 13, wherein the piston and syringe body further define a variable vacuum chamber on a proximal side of the piston, and wherein a proximal seal is disposed between the shaft and the proximal portion of the syringe body to maintain sterility of the variable vacuum chamber.
17. The syringe of claim 13, wherein the barrier is attached directly to the syringe body.
18. The syringe of claim 13, wherein the barrier is disposed over a distal end of the distal portion of the syringe body.
19. The syringe of claim 13, wherein the barrier is hermetically sealed about an outer periphery of the distal portion of the syringe body.
20. A syringe for injecting a patient with fluidic medication in a sterile manner, the syringe comprising:
- a plunger assembly having a piston and a shaft;
- a syringe body having a proximal portion and a distal portion, the piston and shaft disposed within the syringe body with the shaft extending out of the proximal portion of the body, the piston being traversable between a refracted position and a forward position within the syringe body, the piston and syringe body defining a variable fluid chamber disposed on a distal side of the piston with sterile gas disposed therein;
- a barrier forming at least a portion of the variable fluid chamber, the barrier configured to prevent air transfer between an environment and the variable fluid chamber and configured to maintain sterility of the variable fluid chamber; and
- a needle disposed at the distal portion of the syringe body,
- wherein the barrier is breakable to allow fluidic medication to flow into or out of the variable fluid chamber through the needle.
21. The syringe of claim 20, wherein the barrier is attached directly to the syringe body.
22. The syringe of claim 20, wherein the barrier is disposed over a distal end of the distal portion of the syringe body.
23. The syringe of claim 20, wherein the barrier is hermetically sealed about an outer periphery of the distal portion of the syringe body.
24. The syringe of claim 20, wherein the piston and syringe body further define a variable vacuum chamber on a proximal side of the piston, and wherein a proximal seal is disposed between the shaft and the proximal portion of the syringe body to maintain sterility of the variable vacuum chamber.
25. A method of injecting a fluid, the method comprising:
- receiving a syringe with a barrier configured to prevent air transfer between an environment and a variable fluid chamber located within a body of the syringe, the variable fluid chamber disposed on a distal side of a piston, the piston being disposed in a retracted position within the syringe body and sterile gas disposed within the variable fluid chamber;
- puncturing the barrier so that fluidic medication can flow into or out of the variable fluid chamber through a needle disposed at a distal portion of the syringe body;
- traversing the piston towards the distal portion of the syringe body to transfer the sterile gas out of the variable fluid chamber;
- positioning an opening of the needle within fluid in a container;
- traversing the piston towards a proximal portion of the body to transfer the fluid in the container into the variable fluid chamber; and
- injecting the person with the fluid in the variable fluid chamber.
26. The method of claim 25, which includes attaching the needle to the distal end portion of the syringe body.
27. The method of claim 26, wherein puncturing the barrier is performed by attaching the needle to the distal portion of the syringe body.
28. The method of claim 25, wherein puncturing the barrier includes rupturing the barrier along a plurality of score lines.
29. The method of claim 25, which includes threading a syringe end of the needle to the distal portion of the syringe body.
30. The method of claim 25, which includes inserting the needle into a container containing the fluid to be injected into a person.
31. The method of claim 30, wherein traversing the piston towards the distal portion of the body includes transferring the sterile gas within the variable fluid chamber into the container to pressurize the container and assist in subsequent withdrawal of the fluid contained within the container.
32. The method of claim 25, which includes, simultaneously with the traversing step, enlarging a volume of a variable vacuum chamber which is disposed on a proximal side of the piston without the addition of environmental air to induce a vacuum force on the piston toward the retracted position and to maintain sterility of the variable vacuum chamber.
Type: Application
Filed: Nov 21, 2014
Publication Date: Mar 19, 2015
Inventors: Jeffrey Smith (Irvine, CA), Daniel Thayer (Mission Viejo, CA)
Application Number: 14/550,788
International Classification: A61M 5/28 (20060101); A61M 5/34 (20060101); A61M 5/31 (20060101);